These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9410880)

  • 1. Dissociation of LPA-induced cytoskeletal contraction from stress fiber formation by differential localization of RhoA.
    Kranenburg O; Poland M; Gebbink M; Oomen L; Moolenaar WH
    J Cell Sci; 1997 Oct; 110 ( Pt 19)():2417-27. PubMed ID: 9410880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction.
    Kranenburg O; Poland M; van Horck FP; Drechsel D; Hall A; Moolenaar WH
    Mol Biol Cell; 1999 Jun; 10(6):1851-7. PubMed ID: 10359601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho.
    Jalink K; van Corven EJ; Hengeveld T; Morii N; Narumiya S; Moolenaar WH
    J Cell Biol; 1994 Aug; 126(3):801-10. PubMed ID: 8045941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: similarity to thrombin action.
    Jalink K; Eichholtz T; Postma FR; van Corven EJ; Moolenaar WH
    Cell Growth Differ; 1993 Apr; 4(4):247-55. PubMed ID: 7684247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of astrocyte morphology by RhoA and lysophosphatidic acid.
    Ramakers GJ; Moolenaar WH
    Exp Cell Res; 1998 Dec; 245(2):252-62. PubMed ID: 9851865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of type I(alpha) phosphatidylinositol 4-phosphate 5-kinase in neurite remodeling.
    van Horck FP; Lavazais E; Eickholt BJ; Moolenaar WH; Divecha N
    Curr Biol; 2002 Feb; 12(3):241-5. PubMed ID: 11839279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential activation of RhoA and FAK/paxillin leads to ATP release and actin reorganization in human endothelium.
    Hirakawa M; Oike M; Karashima Y; Ito Y
    J Physiol; 2004 Jul; 558(Pt 2):479-88. PubMed ID: 15155793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transduction pathways regulating Rho-mediated stress fibre formation: requirement for a tyrosine kinase.
    Ridley AJ; Hall A
    EMBO J; 1994 Jun; 13(11):2600-10. PubMed ID: 7516876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling.
    Stam JC; Michiels F; van der Kammen RA; Moolenaar WH; Collard JG
    EMBO J; 1998 Jul; 17(14):4066-74. PubMed ID: 9670021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphorylation is involved in reorganization of the actin cytoskeleton in response to serum or LPA stimulation.
    Chrzanowska-Wodnicka M; Burridge K
    J Cell Sci; 1994 Dec; 107 ( Pt 12)():3643-54. PubMed ID: 7706413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RhoA and lysophosphatidic acid are involved in the actin cytoskeleton reorganization of astrocytes exposed to ethanol.
    Guasch RM; Tomas M; Miñambres R; Valles S; Renau-Piqueras J; Guerri C
    J Neurosci Res; 2003 May; 72(4):487-502. PubMed ID: 12704810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho-mediated cytoskeletal rearrangement in response to LPA is functionally antagonized by Rac1 and PIP2.
    Seasholtz TM; Radeff-Huang J; Sagi SA; Matteo R; Weems JM; Cohen AS; Feramisco JR; Brown JH
    J Neurochem; 2004 Oct; 91(2):501-12. PubMed ID: 15447683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The G-protein G13 but not G12 mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to Rho.
    Gohla A; Harhammer R; Schultz G
    J Biol Chem; 1998 Feb; 273(8):4653-9. PubMed ID: 9468525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase A inhibits lysophosphatidic acid-induced migration of airway smooth muscle cells.
    Hirakawa M; Karashima Y; Watanabe M; Kimura C; Ito Y; Oike M
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1102-8. PubMed ID: 17347321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel, putative Rho-specific GDP/GTP exchange factor and a RhoA-binding protein: control of neuronal morphology.
    Gebbink MF; Kranenburg O; Poland M; van Horck FP; Houssa B; Moolenaar WH
    J Cell Biol; 1997 Jun; 137(7):1603-13. PubMed ID: 9199174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells.
    Leve F; Marcondes TG; Bastos LG; Rabello SV; Tanaka MN; Morgado-Díaz JA
    Eur J Pharmacol; 2011 Dec; 671(1-3):7-17. PubMed ID: 21968138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
    Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
    Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid-induced neurite retraction in PC12 cells: control by phosphoinositide-Ca2+ signaling and Rho.
    Tigyi G; Fischer DJ; Sebök A; Yang C; Dyer DL; Miledi R
    J Neurochem; 1996 Feb; 66(2):537-48. PubMed ID: 8592123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid increases intracellular H2O2 by phospholipase D and RhoA in rat-2 fibroblasts.
    Shin I; Kweon SM; Lee ZW; Kim SI; Joe CO; Kim JH; Park YM; Ha KS
    Mol Cells; 1999 Jun; 9(3):292-9. PubMed ID: 10420989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lysophosphatidic acid-induced RhoA activation and tumor cell invasion by 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
    Kusama T; Mukai M; Ayaki M; Imamura F; Tatsuta M; Matsumoto Y; Nakamura H; Inoue M
    Int J Oncol; 2003 Oct; 23(4):1173-8. PubMed ID: 12964001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.